Left Atrial Appendage Occlusion (LAAO) Indications and Interventions Practice Test

These questions are part of the practice quiz. Start practicing

• What parameters were studied in the Watchman FLX trial?
• How can chronic atrial fibrillation affect the success of LAAO procedures?
• What describes the 'chicken wing' LAA shape?
• What is an expected requirement for an LAAO device to pass deployment tests?
• Which type of sedation might be used during LAAO procedures?
• What is a major benefit of using the Watchman device in LAAO procedures?
• Which LAA shape resembles a swimming bird and is more complicated due to its bends?
• What is a contraindication to anticoagulation therapy?
• What is essential follow-up care after LAAO?
• How might the type of atrial fibrillation affect LAAO interventions?
• What is the role of the heart team's multidisciplinary approach in LAAO?
• What are the imaging steps prior to LAAO intervention?
• What age must a patient be to be considered for LAAO?
• What does the presence of severe renal failure indicate regarding anticoagulation therapy?
• Which of the following is NOT a factor in the CHA2DS2-VASc score?
• What key education points should be included for patients prior to LAAO?
• What aspect of atrial fibrillation management is directly influenced by LAAO?
• What is the recommended duration of anticoagulation therapy after LAAO in most cases?
• What is a significant characteristic of the left atrial appendage in patients with atrial fibrillation?
• How is an interatrial septal aneurysm typically visualized in transthoracic echocardiography (TTE)?
• Which views are important for taking left atrial appendage measurements using TEE?
• What potential impact does active infection have on LAAO candidacy?
• What is the long-term goal of LAAO?
• What initial assessment does the device undergo related to its stability?
• How can the effectiveness of LAAO be evaluated?
• What is a primary patient management step following LAAO?
• How does the LAAO procedure differ from traditional cardiac surgeries?
• What is the significance of a new concomitant code in relation to LAAO procedures?
• What are patients deemed suitable for when considering the Watchman FLX procedure?
• What vital aspects are measured in LAA using TEE?
• Why is it necessary to monitor patients on Vitamin K antagonists closely?
• What position should the TEE transducer be closest to during LAA procedures?
• What laboratory test is commonly used to monitor the therapeutic window of Warfarin?
• What role does fluoroscopy play during LAAO procedures?
• What is required for a device to pass the stability criteria during assessment?
• What primary advantage does the ICE transducer provide during the LAAO procedure?
• What does Warfarin do to the body's ability to utilize Vitamin K?
• What is the minimum number of transseptal procedures required for a surgeon to be certified to perform LAAO?
• What does DRT stand for in the context of LAAO?
• In the context of LAAO, what does CHA2DS2-VASc >/= 3 indicate?
• During follow-up, what is crucial for patients who have undergone LAAO?
• How should LAAO device selection be approached in relation to patient anatomy?
• How is LAAO typically assessed after the procedure?
• Which types of patients are typically ineligible for LAAO?
• What is the Watchman FLX?
• Which of the following devices is identified as an LAAO device?
• What are some potential long-term complications after LAAO?
• Which imaging technique is useful for assessing the posterior view for TSP during LAAO?
• Which clinical guideline provides recommendations for LAAO procedures in atrial fibrillation?
• What is a common post-surgical concern for patients undergoing Surgical LAAO?
• What is the normal INR range for a healthy individual?
• Which clinical trials are known for evaluating the effectiveness of LAAO?
• What complication is associated with a swan-shaped LAA?
• Which devices are commonly used for LAAO?
• What type of LAA shape has the highest association with stroke risk?
• What characteristic of a catheter aids in stability during LAAO delivery systems?
• What is a characteristic of DOACs compared to traditional anticoagulants?
• Who is qualified to perform Left Atrial Appendage Occlusion (LAAO) procedures?
• What is the average size range of the left atrial appendage in adults?
• Which iatrogenic complications can arise from LAAO?
• In which setting is LAAO typically performed?
• What shape is described for the disc in the CLOSE criteria?
• What structural heart condition is associated with rheumatic atrial fibrillation?
• Why is the anatomical shape of the left atrial appendage significant for LAAO?
• What does the HAS-BLED score evaluate?
• What are the primary complications associated with LAAO procedures?
• What is a common requirement for successful LAAO patient education?
• What does lobe compression refer to in the context of Amulet device release criteria?
• Post-operative management for patients who have undergone LAAO typically requires what?
• What is a potential consequence of consuming a high amount of Vitamin K while on a Vitamin K antagonist?
• What is the expected time frame for LAAO device integration within the tissue?
• What is the primary function of Vitamin K in blood clotting?
• What should be excluded during a pre-procedural assessment for LAAO?
• Why is patient education essential prior to undergoing LAAO?
• Which factor may lead to a patient experiencing strokes even after LAAO?
• Patients undergoing LAAO procedures are primarily at risk for stroke due to what factor?
• Which of the following is an example of a Direct Acting Oral Anticoagulant (DOAC)?
• What does CHADS2 score assess for?
• Why is the left atrial appendage important in atrial fibrillation?
• How does LAAO impact the quality of life in patients with atrial fibrillation?
• Which of the following is true about a double transseptal puncture (TSP)?
• Which condition is NOT included in the HAS-BLED score?
• What should be the INR range for a patient on Warfarin?
• What complication is particularly associated with the use of LAAO devices?
• What lifestyle changes are recommended after an LAAO procedure?
• What is one of the specific measurements needed when assessing LAA dimensions?
• How does LAAO influence the management of paroxysmal atrial fibrillation compared to persistent atrial fibrillation?
• In the context of atrial fibrillation, what does increased left atrial pressure indicate?
• What was a significant finding from the Protect AF trial?
• For LAAO eligibility, what is the significance of having a CHADS2 score greater than 2?
• Which structure is the ICE transducer closest to when placed?
• Why is the follow-up monitoring essential after LAAO?
• What quadrants should be used for measuring the left atrial appendage (LAA) during transesophageal echocardiography (TEE)?
• What is the function of follow-up echocardiograms after undergoing LAAO?
• How long is the half-life of Warfarin, and what does this imply for procedures?
• What defines the PASS position for the device in LAAO?
• When is the optimal time to image the Left Atrial Appendage (LAA) using CT?
• What is the average procedural success rate for LAAO?
• What is typically required if a pericardial effusion compresses the heart?
• In the context of LAAO, what does the PASS Seal requirement ensure?
• What specific measurements are taken to assess LAA morphology?
• What is a significant risk factor that may lead to the consideration of LAAO?
• Which scoring system must be at least 3 for a patient to be eligible for LAAO?
• What should patients expect during recovery after LAAO?
• In what clinical scenario is LAAO clearly indicated?
• What visual aid can be particularly helpful when visualizing Watchman placement?
• What is the role of anticoagulation therapy in patients undergoing LAAO?
• Which factors are included in CHA2DS2-VASc scoring?
• In relation to TSP, what risk is increased with a second puncture?
• What does the Watchman FLX clinical trial compare?
• How is the size of the device selected for LAAO?
• Which factor is considered an additional contraindication to anticoagulation?
• What is the significance of left atrial enlargement in patients with atrial fibrillation?
• What factor primarily determines the need for LAAO in certain patients?
• What aspect of the Amulet device helps facilitate its function in the LAAO procedure?
• How does structural heart disease affect candidacy for LAAO?
• Which measurement point is critical for evaluating the left atrial appendage using TEE?
• Which cardiovascular risk factors are commonly associated with atrial fibrillation?
• Where do clinicians aim for transseptal access during LAAO placement?
• Why is patient education important regarding LAAO?
• What type of procedure is associated with Surgical LAAO?
• What are CAP and CAP2 studies focused on?
• What should be monitored post-LAAO intervention?
• What aspect of valvular anatomy is assessed using CT imaging?
• What anatomical considerations are critical for selecting LAAO devices?
• Which aspect does NOT typically factor into the evaluation of LAAO effectiveness?
• What is a common post-procedure complication that requires monitoring in LAAO patients?
• Which patient population is most likely to benefit from LAAO procedures?
• Which trial compared the effectiveness of Watchman versus warfarin for stroke risk reduction?
• What type of catheter is typically used for device placement during LAAO?
• What is the primary benefit of LAAO compared to anticoagulation therapy?
• What is a key Medicare indication for LAAO?
• What aspect of patient care is critical before proceeding with LAAO?
• What should be the overall characteristic of the device after passing the seal test?
• What does successful lobe separation imply for the performance of the Amulet LAAO device?
• Post-procedure, what diagnostic tool is frequently used to assess LAAO?
• Which characteristic is relevant to the assessment of LAA morphology?
• What information should be emphasized during patient education regarding LAAO?
• What is the appearance of a thrombus on echocardiography in the left atrial appendage?
• What is the mechanism by which LAAO devices prevent stroke?
• What is a distinctive feature of the Amulet LAAO device?
• Which imaging modality is typically used to assess the anatomy of the left atrial appendage before LAAO?
• What scoring system is commonly used to assess stroke risk in patients with atrial fibrillation?
• During which phase of the cardiac cycle is ECG Gating CT triggered to capture images?
• What factor influences the decision to discontinue anticoagulation therapy after LAAO?
• What does a CHA2DS2-VASc score of 2 or higher indicate?
• What is an expected outcome of successful LAAO in patients with atrial fibrillation?
• What is a potential consequence of performing a transseptal puncture through a patent foramen ovale (PFO)?
• What does a pericardial effusion indicate?
• What should be closely monitored after an LAAO procedure?
• What class of medications is commonly prescribed to patients with atrial fibrillation for stroke prevention?
• What are the release criteria for the Watchman FLX PASS device?
• What should device placement align with during LAA occlusion procedures?
• How does LAAO impact the management of anticoagulation therapy?
• What is a primary indication for patients to undergo Watchman FLX treatment?
• What characterizes a single transseptal puncture (TSP)?
• Which patient population is primarily considered for LAAO procedures?
• Which view is recommended for evaluating the 3D geometry of the LAA during TEE?
• What role do patients have in their post-LAAO care?
• What patient-specific characteristics should be assessed before proceeding with LAAO?
• What does the CLOSE criterion related to separation between device lobe and disc ensure?
• Why is the orientation of the device important when deploying the LAAO device?
• How should the diameter of the left atrial appendage be determined during measurements?
• What is the primary indication for Left Atrial Appendage Occlusion (LAAO)?
• Why are definitions of non-valvular atrial fibrillation important for LAAO eligibility?
• How much should the device be compressed to meet the size pass criteria?
• Which of the following is a long-term complication associated with LAAO?
• What is a contraindication for LAAO?
• When educating patients about LAAO complications, what is a crucial topic to discuss?
• What benefit does LAAO provide when compared to long-term anticoagulation use?
• Which of the following is NOT typically a focus of patient education before LAAO?
• Which of the following statements is true regarding the Amulet and Watchman devices?
• What role does hypertension play in atrial fibrillation?
• What is the primary purpose of performing a pre-procedural CT for LAAO?
• Can LAAO lead to the complete elimination of anticoagulation therapy?
• What is the primary purpose of a Left Atrial Appendage Occlusion (LAAO) device?
• What aspect of anticoagulation management is a consideration for patients undergoing LAAO?
• What hemodynamic changes may occur during LAAO?
• What is a major clinical benefit observed in trials assessing LAAO?
• Which of the following interventions is generally NOT indicated for a patient after LAAO?
• Which anticoagulant is considered a Vitamin K antagonist?
• Which clinical condition is essential for CMS to provide coverage for Watchman FLX?
• What is one of the goals of intra-procedural imaging during LAAO?
• Which medication class requires dietary monitoring, particularly for leafy greens?
• What criterion indicates that the device lobe is adequately positioned relative to the LCx coronary artery?
• What is essential for optimal sealing during the LAAO procedure?